Altos Labs, Inc., founded in 2022, is an American biotechnology research company dedicated to developing life extension therapies aimed at halting or reversing the aging process. The company focuses on specialized cell therapies based on induced pluripotent stem cells to restore cell health and resilience. Altos Labs' mission is to reverse diseases, injuries, and disabilities that occur throughout life, positioning itself at the forefront of the anti-aging and regenerative medicine market.
Notable figures affiliated with Altos Labs include leading scientists and biotech experts who contribute to its pioneering research. The company has garnered significant attention and investment from high-profile investors in the tech and biotech sectors. Key achievements include groundbreaking advancements in cell rejuvenation techniques, positioning Altos Labs as a transformative force in biotechnology with the potential to significantly impact human health and longevity.
